Skip to main content
Convatec Group PLC logo

Convatec Group PLC — Investor Relations & Filings

Ticker · CTEC ISIN · GB00BD3VFW73 LEI · 213800LS272L4FIDOH92 IL Manufacturing
Open in API
Filings indexed 480 across all filing types
Latest filing 2026-04-13 Board/Management Inform…
Country GB United Kingdom
Listing IL CTEC

About Convatec Group PLC

https://www.convatecgroup.com/

Convatec is a global medical products and technologies company focused on developing and marketing solutions for the management of chronic conditions. The company holds leading market positions in its four core franchises: Advanced Wound Care, which includes products for acute and chronic wounds; Ostomy Care, providing devices for people with stomas; Continence and Critical Care, offering solutions for bladder and bowel management; and Infusion Care, which supplies devices for subcutaneous drug delivery, primarily for insulin-dependent diabetes. Its products are designed to improve patient outcomes, prevent infection, protect at-risk skin, and reduce the total cost of care for healthcare providers and patients globally.

Recent filings

Filing Released Lang Actions
Professor Constantin Coussios steps down
Board/Management Information Classification · 1% confidence The document is a Regulatory News Service (RNS) announcement by Convatec Group Plc. It reports a board change – Professor Constantin Coussios OBE stepping down as a Non-Executive Director – and an associated amendment to an AGM resolution. It is an announcement of a board director change, fitting the Board/Management Information category.
2026-04-13 English
Capital Markets Day
Investor Presentation Classification · 1% confidence The document is an RNS press release announcing Convatec’s Capital Markets Day, outlining an updated ‘Accelerate’ strategy, medium-term guidance and event logistics. It is not a financial report (10-K/IR), nor is it a proxy, dividend, earnings release, or financing notice. It clearly presents strategic and growth information aimed at investors as part of a presentation. Therefore, it best fits the Investor Presentation category.
2026-04-09 English
Form of Proxy for 2026 AGM
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Form of Proxy' for Convatec Group Plc's Annual General Meeting. It contains instructions for shareholders to appoint a proxy, vote on specific resolutions (such as director elections, auditor appointments, and dividend declarations), and attend the meeting. This type of document is sent to shareholders to solicit their votes and provide information regarding the meeting agenda, which falls under the definition of a Proxy Solicitation & Information Statement.
2026-03-17 English
Notice of Annual General Meeting 2026
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of Annual General Meeting' for Convatec Group Plc. It contains the agenda, proposed resolutions (ordinary and special), explanatory notes for shareholders, and instructions for voting and proxy appointment. This document is a formal solicitation of shareholder action and information for an upcoming meeting, which fits the definition of a Proxy Solicitation & Information Statement.
2026-03-17 English
Notice of AGM
AGM Information Classification · 1% confidence The document is a short announcement (under 5,000 characters) from Convatec Group PLC regarding the publication and distribution of their Notice of Annual General Meeting and Form of Proxy. It explicitly states that these documents are being sent to shareholders and submitted to the National Storage Mechanism, providing links to where they can be accessed. Per the 'Menu vs Meal' rule, this is an announcement of a report/document rather than the document itself, making it a Report Publication Announcement (RPA).
2026-03-17 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is a formal notification of share transactions by Persons Discharging Managerial Responsibility (PDMR), specifically detailing the vesting of share awards and subsequent sales to cover tax liabilities for the CEO and CFO. It explicitly references 'Director/PDMR Shareholding' and 'Article 19 of the Market Abuse Regulation', which are standard indicators for a Director's Dealing filing.
2026-03-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.